WallStSmart

Alphatec Holdings Inc (ATEC)vsEdwards Lifesciences Corp (EW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Edwards Lifesciences Corp generates 694% more annual revenue ($6.07B vs $764.15M). EW leads profitability with a 17.7% profit margin vs -18.8%. ATEC appears more attractively valued with a PEG of 0.48. EW earns a higher WallStSmart Score of 55/100 (C).

ATEC

Hold

41

out of 100

Grade: D

Growth: 7.3Profit: 2.0Value: 6.7Quality: 5.0

EW

Buy

55

out of 100

Grade: C

Growth: 4.0Profit: 7.0Value: 7.3Quality: 4.8
Piotroski: 2/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ATEC.

EWSignificantly Overvalued (-544.4%)

Margin of Safety

-544.4%

Fair Value

$12.31

Current Price

$82.67

$70.36 premium

UndervaluedFair: $12.31Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ATEC2 strengths · Avg: 9.0/10
PEG RatioValuation
0.4810/10

Growing faster than its price suggests

Revenue GrowthGrowth
20.4%8/10

Revenue surging 20.4% year-over-year

EW1 strengths · Avg: 8.0/10
Operating MarginProfitability
23.7%8/10

Strong operational efficiency at 23.7%

Areas to Watch

ATEC4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.74B3/10

Smaller company, higher risk/reward

Price/BookValuation
143.6x2/10

Trading at 143.6x book value

Return on EquityProfitability
-6.3%2/10

ROE of -6.3% — below average capital efficiency

EW4 concerns · Avg: 2.8/10
PEG RatioValuation
2.144/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

P/E RatioValuation
45.7x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-76.6%2/10

Earnings declined 76.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : ATEC

The strongest argument for ATEC centers on PEG Ratio, Revenue Growth. Revenue growth of 20.4% demonstrates continued momentum. PEG of 0.48 suggests the stock is reasonably priced for its growth.

Bull Case : EW

The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.

Bear Case : ATEC

The primary concerns for ATEC are EPS Growth, Market Cap, Price/Book.

Bear Case : EW

The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.

Key Dynamics to Monitor

ATEC profiles as a growth stock while EW is a mature play — different risk/reward profiles.

ATEC carries more volatility with a beta of 1.04 — expect wider price swings.

ATEC is growing revenue faster at 20.4% — sustainability is the question.

EW generates stronger free cash flow (354M), providing more financial flexibility.

Bottom Line

EW scores higher overall (55/100 vs 41/100), backed by strong 17.7% margins and 13.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alphatec Holdings Inc

HEALTHCARE · MEDICAL DEVICES · USA

Alphatec Holdings, Inc., a medical technology company, designs, develops and advances technologies for the surgical treatment of spinal disorders. The company is headquartered in Carlsbad, California.

Edwards Lifesciences Corp

HEALTHCARE · MEDICAL DEVICES · USA

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.

Visit Website →

Want to dig deeper into these stocks?